Epstein-Barr virus (EBV) is usually acquired silently early in life and carried thereafter as an
asymptomatic infection of the B lymphoid system. However, many circumstances disturb the …

Publisher Summary This chapter focuses on both on the effects of Epstein–Barr virus (EBV)
on human B cells and on the immune response to viral infection. The chapter also presents …

Persistent Epstein–Barr virus (EBV) infection remains asymptomatic in the majority of virus
carriers, despite the potent growth transforming potential of this virus. The increased …

Most primary Epstein–Barr virus (EBV) infections are clinically inapparent, but occasionally
EBV infection can cause acute infectious mononucleosis. EBV has been linked to a variety …

Recent studies indicate that a large proportion of cytotoxic T cells are directed towards the
Epstein-Barr virus (EBV) during both acute infection and convalescence. The virus, in turn …

Human B cells are the primary targets of Epstein–Barr virus (EBV) infection. In most cases,
EBV infection is asymptomatic because of a highly effective host immune response, but …

Epstein-Barr virus (EBV) is a ubiquitous, oncogenic virus that is associated with a number of
different human malignancies as well as autoimmune disorders. The expression of EBV viral …

Publisher Summary The Epstein–Barr virus (EBV) acts as one of a number of factors
including environmental and genetic elements that contribute to the pathogenesis of Burkitt's …

Epstein-Barr virus (EBV) is typically acquired asymptomatically in childhood. In contrast,
infection later in life often leads to infectious mononucleosis (IM), a febrile illness …

Epstein–Barr virus (EBV) is a member of ubiquitous γ herpes viruses, which primarily
induces acute infectious mononucleosis (IM) or subclinical infection in susceptible subjects …